How long does it take to stop dasatinib treatment?

Generally speaking, the withdrawal time for dasatinib may range from 6 months to several years. For patients with chronic myelogenous leukemia (CML), drug discontinuation decisions are often based on whether the patient is able to achieve and maintain a deep molecular response (DMR). Some studies have shown that among CML patients who receive first- or second-line dasatinib and maintain deep molecular remission for at least a certain period of time (such as 1 year or longer), a significant proportion of patients can safely discontinue dasatinib and achieve "treatment-free remission" (TFR). However, these studies also pointed out that patients need to be continuously monitored for changes in their condition after drug withdrawal to prevent disease recurrence.

Patients with milder disease may have an easier time discontinuing medication, while patients with more severe disease may require longer treatment to maintain stable disease. The patient's response to dasatinib treatment directly affects the time to discontinue treatment. If patients are able to achieve deep molecular remission quickly and sustainably, drug withdrawal times may be relatively short. The patient's age, comorbidities, and overall medical condition also influence discontinuation decisions. Patients in better physical condition may be more likely to tolerate post-drug monitoring and follow-up more easily.

The decision to discontinue medication should be made by the physician based on the patient's specific condition and monitoring results. Doctors will comprehensively evaluate the feasibility of discontinuing medication based on the patient's treatment response, changes in condition, and potential risk factors.

It is important to note that stopping the medication does not mean the end of treatment. For patients who still require continuous monitoring after discontinuation of medication, relevant examinations should be performed regularly to evaluate changes in condition and restart treatment if necessary. In addition, patients should also pay attention to maintaining good living habits and performing necessary follow-up and reexaminations as directed by their doctor during the period of drug withdrawal.